EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A 360 μG/WEEK IN COMBINATION WITH RIBAVIRIN IN HEPATITIS C GENOTYPE I PATIENTS WITH CIRRHOSIS: ANALYSIS FROM THE CHARIOT STUDY

被引:1
作者
Cheng, W. S. C. [1 ]
Roberts, S. [2 ]
Weltman, M. [3 ]
Crawford, D. H. G. [4 ]
Sievert, W. [5 ]
McCaughan, G. [6 ]
Rawlinson, W. [7 ]
Desmond, P. [8 ]
Yoshihara, M. [9 ]
Rizkalla, B. [9 ]
DePamphilis, J. [11 ]
Marks, P. [10 ]
Dore, G. J. [10 ]
机构
[1] Royal Perth Hosp, Perth, WA, Australia
[2] Alfred Hosp, Melbourne, Vic, Australia
[3] Nepean Hosp, Sydney, NSW, Australia
[4] Greenslopes Hosp, Brisbane, Qld, Australia
[5] Monash Med Ctr, Melbourne, Vic, Australia
[6] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[7] Prince Wales Hosp, SEALS, Sydney, NSW, Australia
[8] St Vincents Hosp, Melbourne, Vic, Australia
[9] Roche Prod Ltd, Sydney, NSW, Australia
[10] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[11] Roche, Nutley, NJ USA
关键词
D O I
10.1016/S0168-8278(09)60603-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
601
引用
收藏
页码:S221 / S221
页数:1
相关论文
empty
未找到相关数据